Literature DB >> 11249757

Gene therapeutic strategies for neurodegenerative diseases.

V Baekelandt1, B De Strooper, B Nuttin, Z Debyser.   

Abstract

Gene transfer into the central nervous system by ex vivo or in vivo techniques is a rapidly emerging field in neuroscience. Potential applications of gene therapy for the nervous system include not only congenital single gene disorders, but also brain tumors and acquired chronic diseases. Considerable progress has been made in the understanding of neurodegenerative diseases such as Parkinson's and Alzheimer's disease. As a result, gene therapy for Parkinson's, and possibly Alzheimer's disease could be regarded as a realistic alternative to the limited treatment options currently available. In this review, we highlight the most important developments in gene transfer techniques as well as the newest insights in the mechanisms of some neurodegenerative disorders and put these into the perspective of gene therapeutic strategies for the central nervous system.

Entities:  

Mesh:

Year:  2000        PMID: 11249757

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  11 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Cell type- and region-dependent coxsackie adenovirus receptor expression in the central nervous system.

Authors:  Annette Persson; Xiaolong Fan; Bengt Widegren; Elisabet Englund
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

3.  Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.

Authors:  Massimo S Fiandaca; Vanja Varenika; Jamie Eberling; Tracy McKnight; John Bringas; Phillip Pivirotto; Janine Beyer; Piotr Hadaczek; William Bowers; John Park; Howard Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2008-11-27       Impact factor: 6.556

4.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 5.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

6.  DNA-Dependent protein kinase is not required for efficient lentivirus integration.

Authors:  V Baekelandt; A Claeys; P Cherepanov; E De Clercq; B De Strooper; B Nuttin; Z Debyser
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Transferrin-associated lipoplexes as gene delivery systems: relevance of mode of preparation and biophysical properties.

Authors:  Nuno Penacho; Ana Filipe; Sérgio Simões; Maria C Pedroso de Lima
Journal:  J Membr Biol       Date:  2008-02-21       Impact factor: 1.843

8.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

Review 9.  Potential new methods for antiepileptic drug delivery.

Authors:  Robert S Fisher; Jet Ho
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 10.  Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Authors:  Sumit Sarkar; James Raymick; Syed Imam
Journal:  Int J Mol Sci       Date:  2016-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.